Jim Cramer's top 10 things to watch in the stock market Tuesday

President Trump's 8 p.m. ET ultimatum for Iran to reopen the Strait of Hormuz (or face attacks) is rattling markets with the S&P 500 set for a lower open after four straight gains, posing a meaningful market-wide risk. Corporate/analyst moves include Broadcom securing Google AI chip production through 2031 and expanding Anthropic compute, Wells Fargo raising its Intel price target to $55 from $45 while trimming 2026 EPS by 2.6% and boosting 2027 EPS by 8.7%, and Morgan Stanley downgrading Arm to hold (PT $150 from $135). Other notable items: U.S. lawmakers eyeing trade curbs on ASML DUV machines (EUV already blocked in China), Seaport double-downgrading several homebuilders to sell, higher-than-expected Medicare Advantage 2027 rates boosting insurers, and Baird cutting Visa's PT to $375 from $425.

Analysis

The market is trading with a pronounced geopolitical overlay that compresses optionality for cyclicals and tech capex. In this environment, winners will be companies with locked-in, multi‑year revenue streams and customers who have already made switching costs irreversible; losers are vendors whose China exposure or near-term execution risks leave revenue lumpy over the next 3–12 months.

Second‑order effects matter: any new export curbs on DUV equipment will not only dent ASML’s China top line but also reroute orders to legacy suppliers and increase lead times for downstream foundries — that creates a multi‑quarter aftermarket opportunity for firms that can supply tooling subsystems and refurbished capacity. Similarly, AI chip ecosystem deals that consolidate supply with a single contract manufacturer (and the processor partner) concentrate bargaining power and raise barriers for gate‑crashers, widening margins for incumbents but increasing single‑counterparty risk for hyperscalers.

Tactically, the path to alpha is asymmetric optionality around discrete catalysts: near‑term earnings and guidance updates for chipmakers and banks (days–weeks), export control legislative votes (weeks–months), and regulatory clarity on Medicare Advantage (months). Volatility will remain elevated; position sizing should target 2–4% of risk budget per idea and prioritize defined‑loss instruments (spreads, collars) where unilateral tail events (escalation, sudden policy shifts) could flip outcomes sharply.

Key Decisions for Investors

• Pair trade (6–12 months): Long AVGO equity or 9–12 month call debit spread (target +20–35%), financed by short V stock or buying 9–12 month puts (target -25–40%). Rationale: concentrated AI compute wins and attached services should sustain revenue multiple re‑rating; hedge payments cyclicality. Risk: payment network volumes recover faster than feared; stop‑loss on AVGO at -15% and cover short V if V outperforms AVGO by >20% over 30 days.
• Directional long (0–3 months into earnings): Buy INTC call spread into next quarterly report (defined debit spread). Rationale: asymmetric upside from roadmap execution with limited premium paid; reward 2–4x if beat/guide‑up. Risk: execution miss; limit position to 2% portfolio risk, exit on weak guide or margin contraction.
• Relative value (3–6 months): Long UNH (or CVS) equity or buy-to-open call spreads to play Medicare Advantage tailwind (target +15–25%). Use a ~6‑month horizon around enrollment cadence. Risk: policy reversal or enrollment weakness; protect with 10–12% trailing stop or buy protective puts if position >2% of portfolio.
• Tactical short (1–3 months): Short selected homebuilders (LEN.B, KBH, DHI, TOL) via puts or an inverse homebuilder ETF position; target a 20–40% downside capturing spring season softness and mortgage rate sensitivity. Risk: rapid rate reversal or localized inventory clearance; size to 1–2% risk and use staggered exits at -10% and -20% adverse moves.
• Event hedge (3–6 months): Buy ASML 3–6 month put spread to hedge semiconductor capex exposure and potential new export controls (limited cost). Rationale: asymmetric payoff if export curbs tighten; payoff helps offset cyclical tech longs. Risk: false alarm on legislation; keep max premium at <0.5% portfolio risk.